Invitek Molecular GmbH

Invitek Molecular GmbH specializes in in vitro diagnostic (IVD) devices focused on nucleic acid extraction and isolation. Their primary products include kits for isolating DNA and RNA from stool and saliva samples, such as the PSP Spin Stool DNA Basic Kit and SalivaGene DNA Kit. Additionally, they produce oral and respiratory tract specimen containers with additives or media, like the SalivaGene Swab Comfort and SalivaGene Collector, which are designed to preserve specimens for pathogen detection.

Invitek Molecular GmbH is based in the United States. Their devices fall under the classification of Class I in regulatory frameworks, which typically applies to low-risk medical devices. This classification is determined based on factors like the intended use, potential risks, and the body’s interaction with the device. Class I devices are generally subject to fewer regulatory controls but must still comply with applicable IVD regulations.

Yes, Invitek Molecular GmbH’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system is used to track and identify medical devices throughout their distribution and helps ensure traceability and regulatory compliance. Listing in this database is a requirement for many Class I devices in the U.S., particularly those intended for in vitro diagnostic use.

Invitek Molecular GmbH’s devices are classified as Class I under regulatory frameworks. This classification matters because it determines the level of oversight and regulatory requirements they must meet. Class I devices are considered the lowest risk among medical devices, often involving minimal potential harm to users. While they may not require pre-market approval, they still must comply with general controls, such as proper labeling, manufacturing practices, and adherence to IVD regulations to ensure safety and effectiveness.